Torsten Hoffmann

Torsten Hoffmann

Corporate Officer/Principal at
American Chemical Society
59 year
Health Technology
Commercial Services
Consumer Services

Profile

Torsten Hoffmann is a member of the American Chemical Society and the Swiss Chemical Society.
He was the Managing Director & Chief Scientific Officer at Proteros biostructures GmbH.
He was also the Head-Global Roche Postdoc at Roche Holding AG from 1999 to 2015.
In 2017 to 2018, he was the Chief Operating Officer at Silence Therapeutics Plc.
He was an Associate at The Scripps Research Institute and the Chief Scientific Officer at Oryzon Genomics SA. He was also the Chief Scientific Officer & Executive VP at Zealand Pharma A from 2013 to 2015.
Dr. Hoffmann holds a doctorate degree from the Swiss Federal Institute of Technology.
Currently, he holds positions as a member of the American Chemical Society and the Swiss Chemical Society.

Torsten Hoffmann active positions

CompaniesPositionStart
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Torsten Hoffmann

CompaniesPositionEnd
SILENCE THERAPEUTICS PLC Chief Operating Officer 2018-06-20
ZEALAND PHARMA A/S Chief Tech/Sci/R&D Officer 2014-12-31
ROCHE HOLDING AG Corporate Officer/Principal 2014-12-31
ORYZON GENOMICS S.A. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
See the detail of Torsten Hoffmann's experience

Training of Torsten Hoffmann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Services

  1. Stock Market
  2. Insiders
  3. Torsten Hoffmann
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!